Anzeige
Mehr »
Donnerstag, 31.07.2025 - Börsentäglich über 12.000 News
Geheime Millionen-Käufe in Bitcoin & Altcoins - ohne Wallet, ohne Risiko? Jetzt wird's spannend
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DK8U | ISIN: LU2458332611 | Ticker-Symbol: Z45
Stuttgart
30.07.25 | 07:34
8,320 Euro
-1,19 % -0,100
1-Jahres-Chart
ALVOTECH Chart 1 Jahr
5-Tage-Chart
ALVOTECH 5-Tage-Chart
RealtimeGeldBriefZeit
7,9208,16030.07.

Aktuelle News zur ALVOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAlvotech Gears Up to Report Q2 Earnings: Here's What to Expect4
MoAlvotech files automatic mixed securities shelf4
MoAlvotech - 6-K, Report of foreign issuer4
10.07.Alvotech Names Chief Financial Officer4
10.07.Alvotech stärkt Verpackungskapazitäten: Alvotech hat die Übernahme des Schweizer Verpackungsspezialisten ...4
10.07.Alvotech Appoints Linda Jónsdóttir As CFO To Replace Joel Morales2
ALVOTECH Aktie jetzt für 0€ handeln
10.07.Alvotech taps Linda Jónsdóttir as CFO2
10.07.Alvotech names veteran Linda Jónsdóttir finance chief3
10.07.Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer610REYKJAVIK, ICELAND (July 10, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
► Artikel lesen
09.07.Why Is Alvotech Stock Trading Higher On Wednesday?4
09.07.Alvotech - 6-K, Report of foreign issuer1
09.07.Alvotech acquires Ivers-Lee Group3
09.07.Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland378REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines...
► Artikel lesen
06.07.Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma5
04.07.Alvotech: Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers6
02.07.Alvotech: Granting of Stock Options and Vesting of Restricted Share Units3
01.07.Alvotech - 6-K, Report of foreign issuer3
01.07.Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia (certolizumab pegol)496REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
► Artikel lesen
26.06.Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility6
25.06.Alvotech: Main Results of 2025 Annual and Extraordinary General Meeting208REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt...
► Artikel lesen
Weiter >>
105 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1